InvestorsHub Logo
Followers 65
Posts 23946
Boards Moderated 0
Alias Born 11/23/2016

Re: WilliamMunny post# 462372

Tuesday, 06/25/2024 9:39:46 AM

Tuesday, June 25, 2024 9:39:46 AM

Post# of 462925
Wrong! in the sense that there is no approval yet: https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-does-not-refer-eisai-biogen-alzheimers-drug-meeting-notes-2024-03-22/

It goes to show that a drug passing stat sig through a CHMP review is no guarantee that EMA will grant approval. In the case of lequembi, I suspect the EMA may actually not approve the drug due to poor clinical effect vs. risk and cost.

The longer we wait, the sooner we will get rich!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News